Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.CeriBell, Inc. (CBLL) Reports Q3 Loss, Tops Revenue Estimates
CeriBell, Inc. (CBLL) Q3 2026 Earnings Call Transcript
Compared to Estimates, CeriBell, Inc. (CBLL) Q3 Earnings: A Look at Key Metrics
CeriBell Q3 Earnings Call Highlights
Ceribell Reports Third Quarter 2026 Financial Results
Ceribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium Monitoring Solution
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026
Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis
BlackRock Inc. Acquires New Holdings in CeriBell, Inc. $CBLL
Bank of America Corp DE Has $5.86 Million Position in CeriBell, Inc. $CBLL
CeriBell Expands EEG Platform Beyond Seizures With Delirium, Pediatric Push
CeriBell, Inc. (CBLL) Q2 2026 Earnings Call Transcript
Here's What Key Metrics Tell Us About CeriBell, Inc. (CBLL) Q2 Earnings
CeriBell, Inc. (CBLL) Reports Q2 Loss, Tops Revenue Estimates
CeriBell Q2 Earnings Call Highlights
Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review
Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System
Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O'Keefe
Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference